Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
暂无分享,去创建一个
Guido Marcucci | Christoph Plass | Pui-Kai Li | C. Plass | Jiejun Wu | T. Huang | G. Marcucci | D. Perrotti | P. Neviani | Shujun Liu | J. Pang | Pui-Kai Li | J. Fuchs | R. Pavlovicz | L. Rush | Zhongfa Liu | Lai-Chu Wu | Ping Chen | Tim H-M Huang | Chenglong Li | D. Bhasin | Chenglong Li | Ryan E Pavlovicz | Ping Chen | Danilo Perrotti | Hongyan Wang | Zhiliang Xie | Jiejun Wu | Kenneth K Chan | Hongyan Wang | Lai-Chu Wu | Zhiliang Xie | Shujun Liu | Zhongfa Liu | James R Fuchs | Paolo Neviani | Josephine Aimiuwu | Jiuxia Pang | Deepak Bhasin | Laura Rush | J. Aimiuwu | K. Chan | Deepak Bhasin | Jiuxia Pang | Josephine Aimiuwu
[1] M. Caligiuri,et al. Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia. , 2008, Blood.
[2] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[3] David S. Goodsell,et al. A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..
[4] J. Byrd,et al. Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method , 2007, Nucleic acids research.
[5] M W Lowdell,et al. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro , 2006, Leukemia.
[6] John M Bennett,et al. Decitabine improves patient outcomes in myelodysplastic syndromes , 2006, Cancer.
[7] E. Eisenhauer,et al. Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study , 2006, Investigational New Drugs.
[8] F. Lyko,et al. Reactivation of Epigenetically Silenced Genes by DNA Methyltransferase Inhibitors: Basic Concepts and Clinical Applications , 2006, Epigenetics.
[9] H. Hsieh,et al. Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system. , 2006, Bioorganic & medicinal chemistry.
[10] Peter A. Jones,et al. Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.
[11] Byron H. Lee,et al. Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1* , 2005, Journal of Biological Chemistry.
[12] Frank Lyko,et al. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. , 2005, Journal of the National Cancer Institute.
[13] Peter A. Jones,et al. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine , 2005, Molecular Cancer Therapeutics.
[14] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[15] Yan Tang,et al. CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia , 2005, Clinical Cancer Research.
[16] K. Ghoshal,et al. 5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal , 2005, Molecular and Cellular Biology.
[17] Derick R. Peterson,et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. , 2005, Blood.
[18] Zhongfa Liu,et al. Analytical method development and pharmacokinetics studies with parthenolide (NSC 157035) and a water-soluble analog (NSC 734325) , 2005 .
[19] Harikrishna Nakshatri,et al. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase , 2004, Oncogene.
[20] Xianglin Shi,et al. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. , 2004, Carcinogenesis.
[21] I. Merfort,et al. Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. , 2004, Life sciences.
[22] Lisa L. Smith,et al. Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets , 2004, Cancer Research.
[23] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[24] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[25] Ni Ai,et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.
[26] K. Irvine,et al. Glycosylation regulates Notch signalling , 2003, Nature Reviews Molecular Cell Biology.
[27] Manel Esteller,et al. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. , 2003, Cancer research.
[28] Ralf Schirrmacher,et al. Establishment and functional validation of a structural homology model for human DNA methyltransferase 1. , 2003, Biochemical and biophysical research communications.
[29] A. M. Salazar,et al. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] Wei Ye,et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. , 2003, Journal of the National Cancer Institute.
[31] J. Holland,et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] H. Pahl,et al. Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones* , 2001, The Journal of Biological Chemistry.
[33] K. Lunetta,et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] M Elofsson,et al. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. , 2001, Chemistry & biology.
[35] G. Sledge,et al. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide , 2000, Oncogene.
[36] K. Robertson,et al. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. , 2000, Nucleic acids research.
[37] G. Sledge,et al. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. , 2000, Oncogene.
[38] David S. Goodsell,et al. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..
[39] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[40] P. Barr,et al. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs , 1983, Cell.
[41] J. Woynarowski,et al. Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones. , 1981, Molecular pharmacology.
[42] J. R. Cole,et al. Tumor inhibitory agent from Magnolia grandiflora (Magnoliaceae). I. Parthenolide. , 1973, Journal of pharmaceutical sciences.
[43] T. Suzuki,et al. Simple method for portal vein infusion in the rat. , 1973, Journal of pharmaceutical sciences.